Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation in sepsis: all bugs bite equally.

Marcel Levi1, Tom van der Poll

  • 1Department of Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. m.m.levi@amc.uva.nl

Critical Care (London, England)
|March 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to the comment by Gando on the updated definition and scoring of disseminated intravascular coagulation.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Laboratory and Medicine 2.1: Care for What You Wish for.

International journal of laboratory hematology·2026
Same author

Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Organ Dysfunction in Sepsis-associated Intravascular Coagulation.

Juntendo Iji zasshi = Juntendo medical journal·2024
Same author

Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?

Journal of thrombosis and haemostasis : JTH·2024
Same author

The role of thromboinflammation in acute kidney injury among patients with septic coagulopathy.

Journal of thrombosis and haemostasis : JTH·2024
Same journal

45th International Symposium on Intensive Care & Emergency Medicine.

Critical care (London, England)·2026
Same journal

High-resolution monitoring reveals fragmented 24-hour light exposure in intensive care units.

Critical care (London, England)·2026
Same journal

Coronary microvascular function in patients with sepsis and myocardial injury: an invasive coronary physiology study.

Critical care (London, England)·2026
Same journal

Comparative performance of mitral E/e' versus inferior vena cava variability for predicting fluid responsiveness in mechanically ventilated adults with shock.

Critical care (London, England)·2026
Same journal

Different lungs or different patients? Insights into postoperative ARDS.

Critical care (London, England)·2026
Same journal

Predictive validity of SOFA-2: analytical and contextual considerations.

Critical care (London, England)·2026
See all related articles

Sepsis frequently causes blood clotting abnormalities, including disseminated intravascular coagulation (DIC), which contributes to organ failure. These coagulation issues are common in severe sepsis regardless of the infecting microorganism.

Area of Science:

  • Hematology
  • Critical Care Medicine
  • Pathophysiology

Background:

  • Sepsis commonly induces hemostatic abnormalities, from minor lab alterations to severe disseminated intravascular coagulation (DIC).
  • Evidence suggests DIC plays a role in sepsis-induced microvascular dysfunction and organ failure.
  • The PROWESS trial confirmed widespread coagulation system activation in severe sepsis.

Discussion:

  • Patients with severe sepsis exhibit elevated markers of systemic coagulation activation.
  • Physiological anticoagulant proteins are decreased in severe sepsis patients.
  • Fibrinolysis is depressed in the context of severe sepsis.

Key Insights:

  • Disseminated intravascular coagulation (DIC) is a significant complication of sepsis, impacting microcirculation and organ function.

Related Experiment Videos

  • Coagulation disorders in sepsis are not correlated with the specific causative microorganism.
  • Therapeutic strategies targeting coagulation pathways may be crucial for sepsis management.

    • Outlook:

    • Further research into the precise mechanisms linking DIC and organ failure in sepsis is warranted.
    • Investigating novel anticoagulant or procoagulant therapies could improve sepsis outcomes.
    • Understanding the heterogeneity of coagulation abnormalities in sepsis may guide personalized treatment approaches.